Advances in neoadjuvant therapy for HER2-positive breast cancers: a narrative review

BACKGROUND AND OBJECTIVE: Breast cancer (BC) is currently the most frequently diagnosed cancer and the primary cause of cancer-related death among women worldwide. Human epidermal growth factor receptor type 2 (HER2)-positive BC accounts for 14.5–15% of all BCs, with a relatively poor prognosis. Neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qianmu, Wang, Xiaojuan, Yang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445724/
https://www.ncbi.nlm.nih.gov/pubmed/36082097
http://dx.doi.org/10.21037/gs-22-439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445724/
https://www.ncbi.nlm.nih.gov/pubmed/36082097
http://dx.doi.org/10.21037/gs-22-439

Ejemplares similares